In a significant breakthrough in the field of drug repurposing, scientists have discovered that a widely used diabetes medication already taken by millions around the world may offer unexpected protection against a form of blood cancer.
The surprising benefit of metformin in helping to prevent acute myeloid leukemia (AML) among people at high risk of the disease has been uncovered by researchers at the University of Cambridge. The discovery could open new pathways for cancer prevention and offer a life-saving option for those most vulnerable to developing this aggressive blood cancer.
